Santaris Pharma santaris.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Santaris Pharma is a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The LNA Drug Platform and Drug Discovery Engine developed by Santaris Pharma combine the company's LNA chemistry with its highly specialized and targeted drug development capabilities to rapidly deliver potent single-stranded LNA-based drug candidates across a multitude of disease states. The company's research and development activities focus on infectious diseases a...Show all

Santaris Pharma is a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The LNA Drug Platform and Drug Discovery Engine developed by Santaris Pharma combine the company's LNA chemistry with it...Show all

Company (Acquired)

Phone: +45 4517 9800

Fax:

Fremtidsvej 3

Horsholm, DK-2970
Denmark

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Santaris Pharma $108.9M Aug 4, 2014
See all 22 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Santaris Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 19 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 22 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Micromirs Oct 29, 2014 Oct 17, 2017 Patent
Potent lna oligonucleotides for the inhibition of hif-1a expression Mar 27, 2013 Sep 20, 2016 Patent
Antisense design Mar 12, 2013 Aug 30, 2016 Patent
Short interfering rna (sirna) analogues Feb 11, 2014 Mar 29, 2016 Patent
Pharmaceutical composition comprising anti-mirna antisense oligonucleotides Apr 04, 2014 Sep 15, 2015 Patent
See all 53 patents